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Abstract: Caffeine is often used in a variety of forms to enhance athletic performance; however,
research regarding caffeine’s effects on strength and power in female athletes is lacking. Therefore,
the purpose of this study was to analyze the acute effects of caffeine anhydrous (6 mg/kg of body
mass) on jumping performance and maximal strength in female collegiate athletes. Eleven athletes
(19.7 ± 0.9 yrs; 166.4 ± 10.2 cm, 67.7 ± 9.4 kg) performed two testing sessions separated by one week,
and randomly received caffeine or placebo using a double-blind approach. Heart rate, blood pressure,
and tympanic temperature were recorded before athletes received each condition, following 60 min
of quiet sitting, and directly after performance testing. Athletes were assessed on unweighted and
weighted squat jump height (SJH0, SJH20) and countermovement jump height (CMJH0, CMJH20),
isometric mid-thigh pull peak force (IPF), and rate of force development from 0–200 ms (RFD200).
Resting systolic blood pressure was significantly greater following caffeine administration compared
to a placebo (p = 0.017). There were small, significant differences in SJH0 (p = 0.035, g = 0.35), SJH20
(p = 0.002, g = 0.49), CMJH0 (p = 0.015, g = 0.19), and CMJH20 (p < 0.001, g = 0.37) in favor of caffeine
over placebo. However, there was no significant difference in IPF (p = 0.369, g = 0.12) and RFD200
(p = 0.235, g = 0.32) between conditions. Therefore, caffeine appears to enhance jumping performance,
but not maximal strength in female collegiate athletes.
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1. Introduction
Caffeine, the world’s most consumed psychoactive drug, has a number of positive
physiological effects linked to increasing aerobic and anaerobic performance [1–4]. The
mechanisms behind these effects in anaerobic performances have not been definitively
established, although there are several hypotheses. Caffeine has been shown to increase
catecholamines such as epinephrine, leading to increased central nervous system (CNS)
stimulation, possibly contributing to enhanced performance [1,2]. Caffeine has also been
shown to increase the release of calcium from the sarcoplasmic reticulum, thus leading to
enhanced force production [3]. Caffeine supplementation may also increase body temperature [5], which influences muscle contractility [6]. Therefore, caffeine can enhance motor
unit recruitment and rate coding of large muscle groups, possibly explaining increases
in performance [7,8]. One prominent hypothesis for caffeine’s ergogenic effects concerns
its action on adenosine. Adenosine is a neurotransmitter that acts as a CNS depressant,
eliciting multiple cognitive effects such as decreased arousal that could interfere with
physical exertion [4]. Caffeine acts as a non-selective adenosine inhibitor, blunting the
negative effects of adenosine on performance and stimulating the CNS [4].
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A plethora of studies have examined the effects of caffeine on endurance exercise, leading to the general conclusion that caffeine enhances performance in aerobic activities [9–13].
Ivy et al. [9] reported a 7.4% increase in work production in trained cyclists over the course
of a two hour cycling session after receiving two doses of caffeine at 250 mg each compared
to a control group. Additionally, Denadai and Denadai [10] found that time to exhaustion
for untrained males on a cycle ergometer was significantly greater with a 5 mg/kg dose of
caffeine compared to a placebo. Reviews and meta-analyses spanning the last two decades
have also concluded that caffeine improves endurance performance [11–13]. Thus, due to
these ergogenic effects, caffeine is commonly used by endurance athletes.
Conversely, fewer studies have examined the effects of caffeine on anaerobic performance, which has produced conflicting results. Arazi et al. [14] reported a significant
increase in maximal bench press and leg press strength following the consumption of
caffeine by novice male bodybuilders (6 mg/kg). However, Astorino et al. [15] found no
effect when examining the same lifts and dosage in resistance trained men. Beck et al. [16]
also recorded increases in upper body maximal strength in resistance trained men yet
found no change in lower body maximal strength. These findings were confirmed by
a meta-analysis examining 10 studies that concluded that caffeine-induced increases in
maximal strength appeared to be limited to the upper body [17].
Furthermore, multiple studies reported increased power performance (e.g., jump
height, peak power) relative to caffeine consumption [7,18]. For instance, a meta-analysis
by Grigic et al. [17] concluded that caffeine acutely increased vertical jump height in
a mixed subject population (i.e., trained, untrained) compared to a placebo. However,
Williams et al. [19] noted a 350 mg dose of caffeine did not increase peak or mean power
in resistance trained men performing the Wingate power test. Thus, further research is
needed assessing the effects of caffeine on power performance.
Males and females may exhibit different responses to caffeine, such as physiological alterations and performance outcomes due to differences in circulating steroid hormones [20].
Studies examining the effects of caffeine on maximal strength and power in female subjects
are also limited and conflicting [18]. Indeed, multiple researchers have highlighted the
need for studies examining the effects of caffeine on performance in females [17,21,22].
Ali et al. [18] showed that a 6 mg/kg dose of caffeine improved eccentric strength during isokinetic dynamometry, yet Sabblah et al. [23] showed no increase in 1-repetition
maximum (1RM) squat performance in females following a 5 mg/kg dose of caffeine
compared to a placebo. Since single-joint evaluations of strength are less applicable to
anaerobically dominant female athletes compared with multi-joint, lower body strength
tests [24], most studies assess maximal strength using 1RM testing [17,21,23]. However,
multi-joint isometric testing with force platforms (e.g., isometric mid-thigh pull, isometric
squat) may provide additional sensitivity and enhance the ability to detect differences
between caffeine and placebo [25]. Notably, only one study has examined the effects of
caffeine on strength performance using the isometric mid-thigh pull, albeit with recreationally trained females [26]. As for maximal power, several studies examined the effects
of caffeine on power output in females using various methodology (e.g., vertical jumps,
Wingate) [18,22,26,27], with very few finding an increase in power output [18].
Importantly, to the best of our knowledge, only three studies have examined the
effects of caffeine on anaerobic performance in female athletes [18,22,27]. These studies
were limited by the use of tests with poor external validity (e.g., isokinetic dynamometry), inclusion of females using oral-contraceptive steroids, which have been shown to
interfere with caffeine metabolism [18], and lack of physiological measures (e.g., heart rate,
blood pressure, temperature). Goldstein et al. [21] demonstrated a different physiological
response to caffeine in females compared to previous investigations with males [15]. These
findings were later confirmed by Temple et al. [20], furthering the need for additional
examinations of females’ physiological response to caffeine. Furthermore, a review by
Grgic and Del Coso [28] concluded that the assessment of lower body strength with females
implementing caffeine supplementation is warranted due to the equivocal findings in the
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literature thus far. Due to these limitations, further research is needed assessing the effects
of caffeine on multi-joint, lower body strength and power in female athletes. Therefore,
the primary aims of this study were to analyze the acute effects of 6 mg/kg caffeine, a
dose that has been shown to maximize physiological responses to caffeine [29], on (1)
jumping performance and (2) lower body maximal strength in female collegiate athletes.
Secondarily, this study aimed to assess the physiological response to caffeine ingestion
compared to a placebo. We hypothesized that ingestion of caffeine would significantly
increase strength and jumping performance, and elicit a greater physiological response
compared to a placebo.
2. Materials and Methods
2.1. Experimental Approach
A randomized, double-blind, placebo-controlled, crossover design was used for this
study. Athletes received either a placebo or a 6 mg/kg dose of caffeine anhydrous 60 min
prior to testing. This dosage has been shown to maximize caffeine’s effectiveness [29] and
optimize blood-caffeine levels within 60 min [30]. Caffeine was consumed in pill form
along with 250 mL of water. The placebo, sucralose, was administered in the same fashion.
Testing was conducted in the same environmental conditions at the same time of day and
day of the week for both sessions.
Athletes were required to avoid strenuous activity and the ingestion of caffeine or
caffeine-containing foods, a list of which were discussed, for 36 h preceding each of the two
testing sessions. The subjects kept a dietary log for 48 h before the first testing session and
were asked to replicate their diet prior to the second session. Athletes also self-reported
oral contraceptive steroid use and menstrual cycle phase due to their potential effects
on caffeine metabolism [17,18,31,32]. Following an overnight fast, athletes arrived at
the laboratory in a rested and hydrated state. Prior to the first testing session, athletes
completed a questionnaire addressing their health history, menstrual cycle phase, habitual
caffeine ingestion, sleep duration, and sport-related information (i.e., position, years on
the team, number of previous testing sessions performed). A second questionnaire was
then completed assessing subjective stress and recovery states using the short recovery
and stress scale (SRSS) [33]. Physiological measurements were assessed after the second
questionnaire, followed by the administration of the caffeine or placebo. After 60 min of
quiet sitting, physiological measurements were reassessed. Athletes proceeded to complete
a dynamic warm-up followed by vertical jumps and isometric mid-thigh pulls. One week
later, the athletes repeated the same testing procedures with the opposite condition. To
assess the effectiveness of blinding, the athletes were asked if they could identify whether
they received the caffeine supplement or placebo.
2.2. Participants
Eleven female collegiate volleyball players (n = 8) and weightlifters (n = 3) participated
in this study (Table 1). The athletes regularly performed the tests conducted in this
study as part of an on-going athlete monitoring program. However, to ensure adequate
familiarization, only athletes who had completed at least two prior testing sessions as part
of the monitoring program were eligible to participate. Any athlete under the age of 18 or
with lower body injuries less than 3 months prior to testing was excluded from the study.
Prior to data collection, athletes received information about the purpose of the study and
provided written informed consent. The study received approval from the university’s
institutional review board (IRB# 0919.23s).

Nutrients 2021, 13, 2496

4 of 12

Table 1. Participant demographics.
Title 1

Mean

Range

Age (yrs)
Height (cm)
Mass (kg)
Experience (yrs) *
Daily Caffeine Intake (mg) #

19.7 ± 0.9
166.4 ± 10.2
67.7 ± 9.4
1.9 ± 1.2
90.4 ± 85.7

18.1–21.3
149.0–178.0
54.1–85.0
1.0–5.0
14.0–312.0

* Years of experience at the collegiate level, # self-reported.

2.3. Procedures
2.3.1. Randomization
An assistant, unaffiliated with the study, used a coin flip to randomly assign the
condition. Each participant received a randomized condition during session one and
received the opposite condition during session two. Every procedure detailed below was
repeated during sessions one and two.
2.3.2. Anthropometrics and Hydration
Upon arrival to the laboratory, hydration was evaluated prior to testing using a
refractometer (ATOGO, Tokyo, Japan). The athletes were considered hydrated if urine
specific gravity (USG) was <1.020. If an athlete failed testing, they continued to consume
water until passing the test. A calibrated scale (Tanita BF-350, Arlington Heights, IL, USA)
was used to measure body mass to the nearest 0.1 kg. Height measurements were recorded
to the nearest 0.5 cm using a stadiometer (Cardinal Scale Manufacturing Co., Webb City,
MO, USA).
2.3.3. Questionnaires
The questionnaires were administered during the five minutes of quiet sitting following anthropometrics and hydration. The first questionnaire asked participants to report
their health history, menstrual cycle phase, habitual caffeine ingestion, sleep duration, and
sport-related information, while the second assessed overall stress and overall recovery
state using the SRSS [33].
2.3.4. Condition Administration and Physiological Measurements
Upon completing hydration testing, athletes sat quietly for five minutes. After five
minutes of quiet sitting a technician took each athlete’s heart rate (HR), blood pressure (BP)
(Omron Blood Pressure Monitor, Lake Forest, IL, USA), and tympanic temperature (TT)
(Braun ThermoScan 5, Kronberg, Germany) (T1). The placebo (Splenda, Heartland Food
Products Group, Carmel, IN, USA) or caffeine (W222402-1KG-K, Sigma-Aldrich, Saint
Louis, MO, USA) supplement was then administered in pill form, followed by 60 min of
quiet sitting. At the end of this period, HR, BP, and TT were recorded again (T2). Within
60 s of completing performance testing, HR, BP, TT, and session rating of perceived exertion
(RPE, 1–10 scale) were recorded in the same seated position (T3).
2.3.5. Standardized Warm-Up
Each athlete performed a standardized warm-up consisting of 25 jumping-jacks,
5 repetitions of mid-thigh pulls with a 20 kg barbell, and 3 sets of 5 repetitions of mid-thigh
pulls with 40 kg. Each set was followed by 60 s of rest.
2.3.6. Vertical Jumps
Upon completing the standardized warm-up, athletes were given two minutes of
rest and then proceeded to vertical jump testing. The athletes performed squat jumps (SJ)
followed by countermovement jumps (CMJ) (Figure 1). All jumps were completed on dual
force plates (Rice Lake Weighing Systems, Rice Lake, WI, USA; 1000 Hz sampling rate)
placed on a 91.4 cm × 91.4 cm custom built jumping platform [34]. For unweighted jumps,
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to eliminate the use of arm swing while jumping. For the weighted jumps, a 20 kg bar was
used. Athletes were told to squat down to the “ready position,” a 90° knee angle measured
with a handheld goniometer. After hearing the command of “3, 2, 1, jump!”, they gave a
maximum effort jump. Warm-ups for SJ were performed at 50% and 75% perceived effort
5 of CMJ
12
prior to at least two maximal effort jumps. The athletes then moved on to the
test
where they were instructed to stand still and await the command of “3, 2, 1, jump!” before
descending to a self-selected depth and jumping. CMJ at 75% perceived effort preceded
the two maximal effort trials with a 60 s rest in between. If the difference in jump height
athletes placed a near weightless (<1 kg) polyvinyl chloride (PVC) pipe on their shoulders
was greater than 2 cm, additional trials were performed.
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the two maximal effort trials with a 60 s rest in between. If the difference in jump height
was greater than 2 cm, additional trials were performed.

Figure 1. Performance testing. Panel (A) depicts the start and flight phase of squat jump testing, panel (B) depicts
countermovement
jump testing,
and panel
depicts
the
isometric
mid-thigh
pullof
positioning.
Figure 1. Performance
testing.
Panel(C)
(A)
depicts
the
start and
flight phase
squat jump testing, panel (B) depicts coun-

termovement jump testing, and panel (C) depicts the isometric mid-thigh pull positioning.

Loaded and unloaded squat jump height (SJH0, SJH20) and countermovement jump
height (CMJH0, CMJH20) were recorded and analyzed using a custom analysis program
(LabView 2010, National Instruments Co., Austin, TX, USA). The mean of two trials’ <2 cm
difference in jump height was used for analysis. Jump height was estimated from flight
time as described by Linthorne [35]. Test–retest reliability has been reported previously
for jump height from our laboratory (intraclass correlation coefficient (ICC) = 0.98, and
coefficient of variation (CV) = 2.20%) [36,37].
2.3.7. Isometric Mid-Thigh Pulls
After completing SJ testing, athletes performed isometric mid-thigh pulls on dual
force plates (Rice Lake Weighing Systems, Rice Lake, WI, USA; 1000 Hz sampling rate)
covering an area of 91.4 cm × 91.4 cm (Figure 1) [34]. The isometric mid-thigh pulls were
performed inside of a custom designed power rack with a fixed bar that was adjusted to
suit each athlete’s mid-thigh position. The athletes were put into their respective pulling
positions while remaining upright with a knee angle of 125 ± 5◦ and hip angle of 145 ± 5◦
measured with a handheld goniometer. The athletes were then secured to the bar in their
respective power clean grip positions using lifting straps and athletic tape to control for
grip strength (Figure 1). The athletes were given the command “steady tension on the bar”,
indicating the need to remain stable. The tester then shouted “3, 2, 1, pull!” and athletes
pulled until peak force was reached and the tester told them to stop. Warm-up attempts at
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50% and 75% perceived effort were performed preceding maximal effort attempts. For the
maximal effort pulls, the athletes received loud, verbal encouragement and were instructed
to pull as “fast and hard” as possible. If a countermovement on the force–time curve of
>200 N was detected, the athlete was given another attempt. The test was terminated
if a consistent decrease or plateau in peak force was observed. An additional trial was
also administered if a difference in peak force of >250 N between the first two trials. Rest
periods of three minutes were allotted between attempts.
All isometric peak force (IPF) values reported were gross values not offset by the
athlete’s body mass on the force plate and were subsequently allometrically scaled for
body mass (IPFa) [38]. Average rate of force development (RFD) from 0 to 200 ms (RFD200)
was considered for the analysis. Analog data from the force plate were amplified and
conditioned (low pass at 16 Hz) with a Transducer Techniques amplifier and conditioning
module (Temecula, CA, USA). An analog–digital converter (DAQCard-6063E, National
Instruments, Austin, TX, USA) was used for collection at 1000 Hz. A custom analysis
program (LabView 2010, National Instruments Co., Austin, TX, USA) was used to analyze
the mean of two trials within 250 N. Test–retest reliability has been previously reported for
IPF and RFD from our laboratory (ICC = 0.95, 0.83, CV = 2.83%, 12.01%, respectively) [39].
2.4. Statistics
The dataset was initially screened for outliers (mean ± 3 SD) followed by a Shapiro–
Wilks test to assess normality and Mauchly’s test to assess sphericity. A paired samples
t-test was used to compare performance results between conditions. A repeated measures
ANOVA followed by post-hoc comparisons was used to analyze changes in physiological
measures between and within conditions. Alpha level for all analyses were set at p < 0.05
and a Benjamini–Hochberg adjustment was used to correct for multiple comparisons [40].
Effect sizes were determined using Hedge’s gav with 95% confidence intervals (CIs), and
classified using the following scale: <0.2 (trivial); 0.2–0.6 (small); 0.6–1.2 (moderate); 1.2–2.0
(large); 2.0–4.0 (very large); >4.0 (nearly perfect) [41]. Individual changes in performance
measures following caffeine administration were considered meaningful if they exceeded
the typical error. A power analysis conducted with G*POWER 3.1 (Universität Kiel,
Germany) determined that 34 participants were needed in the present study for a power
of 0.80, with an effect size of 0.5 and an α= 0.05. Analyses were performed using SPSS
software version 25 (IMB Co., New York, NY, USA), and Microsoft Excel 2016 (Microsoft
Corporation, Redmond, WA, USA).
3. Results
3.1. Hydration and Questionnaires
There were no significant differences between testing sessions for body mass, USG,
or any SRSS items. Eight of the eleven participants were able to correctly identify the
caffeine condition.
3.2. Physiological Measurements
There were statistically significant time effects for HR (F (5, 50) = 10.645, p < 0.001,),
SBP (F (2.625, 26.248) = 8.414, p = 0.001), DBP (F (5, 50) = 3.321, p = 0.011), and TT (F (5,
50) = 5.462, p < 0.001). Post-hoc analyses revealed statistically significant increases in HR
(p < 0.001, p = 0.003), SBP (p = 0.001, p = 0.002), DBP (p = 0.024, p < 0.001), and TT (p = 0.039,
p = 0.003) from T1–T3 in the placebo and caffeine conditions, respectively. There were also
statistically significant increases in SBP (p < 0.001) and DBP (p = 0.009) from T1–T2 in the
caffeine condition. SBP was significantly greater in the caffeine condition compared to the
placebo at T2 (p = 0.017). There were no significant differences in RPE between caffeine
and placebo (5.73 ± 1.78 and 5.59 ± 1.46, respectively) (Table 2).
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Table 2. The effects of caffeine on physiological measurements.
Physiological Variables
Placebo Condition

Time Point 1

Time Point 2

Time Point 3

Heart Rate (beats/min)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Tympanic Temperature (F)

79 ± 12
110 ± 8
73 ± 5
97.7 ± 0.8

75 ± 11
110 ± 8
75 ± 7
97.8 ± 0.6

92 ± 12 *
121 ± 4 *
77 ± 7 *
98.4 ± 0.8 *

74 ± 11
108 ± 6
71 ± 6
97.5 ± 0.9

71 ± 6
117 ± 9 *,#
76 ± 7 *
97.6 ± 0.8

91 ± 14 *
122 ± 10 *
79 ± 8 *
98.5 ± 1.0 *

Caffeine Condition
Heart Rate (beats/min)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Tympanic Temperature (F)

* Significant increase compared to Time Point 1 (p < 0.05), # Significant increase compared to the placebo (p < 0.05).

3.3. Performance Measurements
There were small, statistically significant differences in SJH0 (p = 0.035, g = 0.35),
SJH20 (p = 0.002, g = 0.49), CMJH0 (p = 0.015, g = 0.19), and CMJH20 (p < 0.001, g = 0.37) in
favor of caffeine over the placebo. There were no significant differences in IPF (p = 0.369,
g = 0.12), IPFa (p = 0.20, g = 0.13), and RFD200 (p = 0.235, g = 0.32) between caffeine and
the placebo (Table 3). Analysis of individual performance changes revealed that 9 of 11
athletes improved SJH 20 kg (+0.5 to 2.7 cm), 10 of 11 athletes improved CMJH 20 kg (+0.8
to 2.3 cm), and 6 of 11 athletes improved IPF (+190.26 to 391.84 N) in the caffeine condition
over the placebo relative to the typical error for each measurement (Figure 2).
Table 3. The effects of caffeine on performance parameters.
Performance Variables

Placebo

Caffeine

p-Value

Hedge’s g [95% CI]

Typical Error

SJH 0 kg (cm)

23.49 ± 3.15

24.55 ± 2.86

0.035 *

0.35 [0.08, 0.63]

1.02

SJH 20 kg (cm)

15.79 ± 2.26

16.98 ± 2.56

0.002 *

0.49 [0.25, 0.74]

0.69

CMJH 0 kg (cm)

25.30 ± 3.77

26.00 ± 3.23

0.015 *

0.19 [0.07, 0.33]

0.55

CMJH 20 kg (cm)

17.05 ± 2.84

18.15 ± 3.03

<0.001 *

0.37 [0.24, 0.50]

0.43

IPF (N)

2976.15 ± 566.13

3043.76 ± 565.06

0.369

0.12 [−0.07, 0.31]

168.57

0.67 )

177.68 ± 31.46

181.49 ± 28.17

0.2

0.13 [−0.08, 0.34]

10.32

(N·s−1 )

4921.85 ± 1693.07

5455.67 ± 1596.08

0.235

0.32 [−0.10, 0.75]

990.63

IPFa (N/kg
RFD 200 ms

* Significant difference between conditions (p < 0.05); SJH = squat jump height; CMJH = countermovement jump height; IPF = isometric
peak force; IPFa = allometrically scaled isometric peak force; RFD = rate of force development; CI = confidence intervals.
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4. Discussion
The main finding of this study was that ingestion of a 6 mg/kg dose of caffeine has a
small, significant effect on jumping performance in female collegiate athletes. However,
maximal isometric strength was not significantly affected by caffeine consumption. The
only physiological measurement that was significantly altered by caffeine compared to the
placebo was resting SBP. There were no significant changes in RPE between conditions.
These results support our hypothesis that caffeine would enhance jumping performance;
however, the results failed to show a significant increase in maximal strength, and the
difference in physiological response was minimal compared to the placebo.
The increases in jumping performance recorded in the present study are consistent
with previous studies [7,42]. Bloms et al. [7] found statistically significant increases in SJH
and CMJH, peak force, and average RFD in male and female collegiate athletes following
5 mg/kg of caffeine compared to a placebo. Diaz-Lara et al. [42] also recorded increased
CMJ height and velocity at peak power in male Jiu-jitsu athletes following the ingestion of
3 mg/kg of caffeine. Furthermore, a meta-analysis by Grgic et al. [17] concluded that acute
caffeine ingestion can be effective for enhancing jumping performance.
However, the current study is the first to show caffeine’s benefits on jumping performance in a strictly female athlete sample. Notably, 10 of 11 athletes improved loaded
CMJH in the caffeine condition (+0.8 to 2.3 cm), indicating a consistent beneficial effect
over placebo. Ali et al. [18] showed no significant differences in CMJH or estimated leg
power in female athletes following 6 mg/kg of caffeine ingestion when compared to a
placebo. In agreement, Arazi et al. [27] failed to show improvements in the Sargent vertical
jump test in teenage female karate athletes following 2 or 5 mg/kg of caffeine compared to
a placebo. However, Ali et al. [18] only examined female athletes using oral contraceptive
steroids, which have been shown to significantly extend the elimination half-life of caffeine
and may have influenced the results [18,31,32,43]. Furthermore, Arazi et al. [27] performed
jump testing after 1RM testing and muscular endurance testing, in which repetitions with
60% of 1RM were performed until volitional failure. Although testing order was controlled
between conditions, it is possible athletes’ jumping performance was compromised due to
accumulative fatigue.
This investigation is also the first to examine caffeine’s effects on isometric midthigh pull performance in female collegiate athletes. Based on our findings, no increases
were observed in the caffeine condition compared to a placebo. In contrast to jumping
performance, only 6 of 11 athletes improved IPF (+190.26 to 391.84 N) in the caffeine
condition over placebo. However, other studies have investigated strength performance
using different methodologies [18,27]. Ali et al. [18] used isokinetic dynamometry, finding
increases in eccentric knee flexion after the ingestion of 6 mg/kg of caffeine. Arazi et al. [27],
on the other hand, found no increase in strength performance when using a 1RM leg press
test to evaluate caffeine’s effects on strength performance. Nonetheless, Arazi et al. [27]
only included teenage female athletes, who had comparatively less training experience.
Considering caffeine may have larger ergogenic effects on trained muscle [15,22,44], this
could partly explain the discrepancy between Ali et al. [18] and Arazi et al. [27] in caffeine’s
effects on strength performance. Meta-analytic results suggest caffeine’s effect on maximal
strength performance is small (effect size ~0.20) compared to a placebo [17,28]. Thus, with
a sample size of 11 athletes, it is possible our study was underpowered. Nonetheless,
our results agree with the meta-analyses by Grgic et al. [17] and Grgic and Del Coso [28]
showing no effect of caffeine on lower-body maximal strength.
Caffeine has been shown to illicit different physiological responses in females compared to males [20,21]. A statistically significant difference in physiological measurements
between conditions occurred only in resting SBP at T2 in favor of caffeine. These findings
agree with Goldstein et al. [21] who found SBP to be significantly affected by caffeine, while
HR and DBP remained unchanged. However, Goldstein et al. [21] found SBP was only
significantly altered in the caffeine condition after testing, while the current study found
differences only at rest after caffeine administration. In contrast, Astorino et al. [15] found
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caffeine affected multiple physiological variables (HR, SBP) when compared with a placebo
in males. Temple et al. [20] found that females exhibited greater changes in blood pressure
but not in heart rate compared to males, possibly explaining the difference between the
aforementioned studies [15,21]. Differences in physiological responses may also be due to
inter-individual differences in caffeine habituation or metabolism [20,21,45]. Future studies
should examine the influence of caffeine habituation and individual caffeine metabolism
on strength and power performance, specifically in female athletes. No statistically significant differences in RPE were detected between conditions. Although some studies have
shown caffeine to reduce RPE when compared with a placebo [27], our findings agree with
previous literature suggesting that RPE is inadequate in detecting changes in perception at
very high intensities [4].
In regard to physiological mechanisms, the increases in jumping performance following caffeine ingestion observed in this investigation could be due to enhanced motor
unit recruitment and rate coding of large, lower-body muscle groups through caffeine’s
excitatory effect at the supraspinal level [7,8]. Furthermore, caffeine blunts pain perception
during exercise through its action on adenosine receptors, which may increase maximal
voluntary contractile force [4]. Therefore, caffeine’s action as an adenosine antagonist
remains a strong prospect to explain caffeine’s effects on jumping performance in this
investigation. Caffeine has also been shown to increase alertness, decrease reaction time,
and possibly improve logical reasoning, all of which may lead to increase performance in
sport as well as laboratory testing [46]. Nonetheless, 8 of 11 athletes correctly identified
the caffeine condition, suggesting inadequate blinding may have influenced our results.
While difficult in practice, future investigations should develop novel strategies to control
for blinding in caffeine research.
The findings presented in this study are relevant to female athletes whose sports
involve high force output and power production, especially for sports that include jumping
(e.g., volleyball, basketball). However, there are several limitations to the current study.
Among these limitations were a small sample size, an inability to adequately blind the
conditions, and the examination of a single dosage of caffeine. Furthermore, the current
study did not control for inter-individual differences in caffeine habituation or metabolism.
Future research should address these issues by amassing a larger sample size, determining
ways to adequately blind caffeine, examining multiple doses of caffeine (e.g., 3 or 5 mg/kg),
and controlling for high vs. low responders to caffeine.
5. Conclusions
Despite the prevalent use of caffeine as an ergogenic aid in athletics, very little research has examined the effects of caffeine on strength and power in female athletes. Our
findings indicate that a 6 mg/kg dose of caffeine has a small, significant effect on jumping
performance in female collegiate athletes. These effects were not observed in measures of
maximal strength. The only physiological measurement that was significantly altered by
caffeine compared to the placebo was resting SBP. Future research should aim to examine
the acute effects of caffeine ingestion on maximal strength and jumping performance in a
larger sample of female athletes, and develop novel strategies to control for blinding.
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